DSA技术在肝癌合并肝动脉-门静脉瘘介入治疗中的应用研究  

Application of DSA Technique in the Interventional Treatment of Liver Cancer with Hepatic Artery-portal Vein Fistula

作　　者：聂关宁 李明军 NIE Guanning;LI Mingjun(Interventional Medicine Department,Linyi Central Hospital,Linyi 276400,Shandong,China)

机构地区：[1]临沂市中心医院介入医学科,山东临沂276400

出　　处：《系统医学》2025年第4期61-64,共4页Systems Medicine

摘　　要：目的分析肝癌合并肝动脉-门静脉瘘患者在数字减影血管造影(digital subtraction angiography,DSA)下进行介入治疗的价值。方法非随机选取2022年1月—2023年12月临沂市中心医院介入医学科114例肝癌合并肝动脉-门静脉瘘患者为研究对象,按治疗方式不同分为常规组(n=57,射频消融治疗)和研究组(n=57,DSA技术辅助下进行介入治疗)。比较两组谷丙转氨酶(alanine aminotransferase,ALT)、血清甲胎蛋白(alpha-fetoprotein,AFP)、临床疗效和并发症发生率。结果研究组患者ALT为(72.19±3.20)U/L,优于常规组的(112.10±10.41)U/L,研究组患者AFP为(350.89±54.21)μg/L,优于常规组的(532.31±89.27)μg/L,差异有统计学意义(t=26.132、8.781,P均<0.05);研究组治疗有效率高于常规组,研究组并发症发生率低于常规组,差异有统计学意义(P均<0.05)。结论对于肝癌并出现肝动脉-门静脉瘘并发症的患者,在DSA技术的辅助下采取介入手术的治疗方法,可以提高临床治疗效果。Objective To analyze the value of interventional treatment with the help of digital subtraction angiography(DSA)in patients with liver cancer complicated with hepatic artery portal vein fistula.Methods From January 2022 to December 2023,a total of 114 patients with liver cancer complicated with hepatic artery portal vein fistula from the Interventional Medicine Department of Linyi Central Hospital were non-randomly selected as the research objects.According to different treatment methods,they were divided into the conventional group(n=57,radiofrequency ablation treatment)and the research group(n=57,DSA assisted intervention treatment).The alanine aminotransferase(ALT),serum alpha fetoprotein(AFP),clinical efficacy and complication rate were analyzed in both groups of patients.Results The ALT level of patients in the study group was(72.19±3.20)U/L,which was better than(112.10±5.41)U/L of the conventional group;the AFP level of patients in the research group was(350.89±54.21)μg/L,which was better than(532.31±89.27)μg/L of the conventional group,and the differences were statistically significant(t=26.132,8.781,both P<0.05).The treatment effectiveness rate of the research group was higher than that of the conventional group,and the incidence of complications in the research group was lower than that of the conventional group,and the differences were statistically significant(both P<0.05).Conclusion For patients with hepatocellular carcinoma and complications of hepatic artery-portal vein fistula,interventional surgery assisted by DSA technology can improve the clinical treatment effect.

关 键 词：肝动脉-门静脉瘘 数字减影血管造影 血清甲胎蛋白 肝癌 

分 类 号：R735[医药卫生—肿瘤]